Acorda Therapeutics, Inc. (ACORQ)

Acorda Therapeutics Revenue

Acorda Therapeutics had revenue of $20.29M in the quarter ending March 31, 2024, a decrease of -8.85%. This brings the company's revenue in the last twelve months to $115.66M, down -2.22% year-over-year. In the year 2023, Acorda Therapeutics had annual revenue of $117.63M, down -0.79%.

• Revenue (ttm): $115.66M
• Revenue Growth: -2.22%
• P/S Ratio: 0.00
• Revenue / Employee: $1,133,961
• Employees: 102
• Market Cap: 12.42K

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	117.63M	-933.00K	-0.79%
Dec 31, 2022	118.57M	-10.51M	-8.14%
Dec 31, 2021	129.07M	-23.90M	-15.62%
Dec 31, 2020	152.97M	-39.44M	-20.50%
Dec 31, 2019	192.41M	-279.03M	-59.19%